Prenatal Screening and Diagnostic Testing

ClariTest^® Core Non-Invasive Prenatal Screening

ClariTest^® Core is a non-invasive prenatal screen (NIPS) that identifies the risk for fetal chromosomal abnormalities. ClariTest Core, a safe and simple blood draw performed as early as 10 weeks gestation, screens for the most common trisomies, sex chromosome abnormalities, and 22q11.2 microdeletions. Learn more about ClariTest Core.

Maternal Serum Screening

GenPath offerings include a number of blood tests that can provide a risk assessment for Down syndrome, trisomy 18, and open neural tube defects (ONTDs) that affect a pregnancy. Learn more about maternal serum screening.